TABLE 5.

Proposed miRNAs panel with potential use for the discrimination between control or bening prostatic hyperplasia populations and prostate cancer patients. Using each miRNA as an array element, the table shows the reporting frequency for each miRNA and the studies where they were reported.

Item	Frequency occurrences	References of studies
miR-21-5p	4	(Samsonov et al., 2016)
		Foj et al. (2017)
		Koppers-Lalic et al. (2016)
		Bryzgunova et al. (2019)
miR-375	3	Foj et al. (2017)
		Koppers-Lalic et al. (2016)
		Davey et al. (2020)
miR-125	2	Bryzgunova et al. (2019)
		Konoshenko et al. (2020)
miR-19b	2	Bryzgunova et al. (2016)
		Konoshenko et al. (2020)
miR-191	2	Lekchnov et al. (2018)
		Bryzgunova et al. (2019)
miR-200	2	Bryzgunova et al. (2019)
		Konoshenko et al. (2020)
miR-30b	2	Lekchnov et al. (2018)
		Matsuzaki et al. (2021)
miR-574-3p	2	Samsonov et al. (2016)
		Davey et al. (2020)